Valeant psoriasis drug safety challenging to assess -FDA Staff

July 15 (Reuters) - Valeant Pharmaceuticals International

Inc's experimental drug to treat the skin disorder

psoriasis carries several potential risks that are challenging

to assess due to limited...

Read more